ASCO GI 2023 Conference Coverage


 

ASCO GI 2023 Phase II Clinical Trial to Study the Use of Cabozantinib in Patients With HCC Post IO Treatment

0 views
March 22, 2023
Comments 0
Login to view comments. Click here to Login